.Zevra Therapeutics' rare ailment medicine seems to become on the course to approval this loss after...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has blown a $230 thousan...
.After greater than twenty years of work with neurodegenerative illness, Swiss biotech AC Invulnerab...
.GSK has actually ditched a period 2 human papillomavirus (HPV) vaccination coming from its pipeline...
.OS Therapies will certainly provide on the NYSE American supply exchange this morning by means of a...
.ALX Oncology's stage 2 stomach cancer cells action fee has compromised. After viewing its own CD47 ...
.Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of expectations, trigg...
.While Biogen's pharma peers are actually hunting for late-stage resources along with little bit of ...
.Instil Bio has actually been a biotech trying to find a pipeline after it junked its lead possessio...
.Biogen has restored legal rights to an early Alzheimer's condition plan to Denali Therapies, leavin...